+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033- Product Image
Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033- Product Image
New

Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 136 Pages
  • July 2025
  • Region: Global
  • Grand View Research
  • ID: 5914578
Description Jump to:
The global oncology based molecular diagnostics market size was estimated at USD 3.75 billion in 2024 and is projected to reach USD 6.35 billion by 2030, growing at a CAGR of 5.5% from 2025 to 2033. This market supports the detection, prognosis, and monitoring of various cancers by identifying genetic mutations, gene expression patterns, and tumor-specific biomarkers through molecular techniques.

Growth is driven by the increasing global cancer burden, growing adoption of precision medicine, and continued innovation in diagnostic technologies such as PCR, NGS, and liquid biopsy platforms.

In addition, rising demand for early cancer detection and personalized therapeutic strategies contributes to market expansion across healthcare systems.

Oncology-based molecular diagnostics involve analyzing DNA, RNA, or proteins to detect cancer-related genetic alterations and guide clinical decisions. These tests help identify specific mutations, gene expressions, or biomarkers associated with various cancers, allowing for more accurate diagnosis, prognosis, and treatment selection. They are commonly used to detect breast, lung, colorectal, and prostate cancers.

These diagnostics play a key role in personalized medicine by helping match patients with targeted therapies and monitoring treatment response. Applications span across hospital labs, reference labs, and research institutions. With continuous improvements in technologies like PCR, next-generation sequencing (NGS), and liquid biopsy, these tests are becoming more efficient and accessible. With oncology care shifting toward individualized treatment, molecular diagnostics have become a critical component of cancer management.

Global Oncology Based Molecular Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global oncology based molecular diagnostics market report based on product, technology, type, and region:

Type Outlook (Revenue, USD Million; 2021 - 2033)

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Kidney Cancer
  • Others

Product Outlook (Revenue, USD Million; 2021 - 2033)

  • Instruments
  • Reagents
  • Others

Technology Outlook (Revenue, USD Million; 2021 - 2033)

  • PCR
  • In situ hybridization
  • INAAT
  • Chips and microarrays
  • Mass spectrometry
  • Sequencing
  • TMA
  • Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
ac

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Oncology Based Molecular Diagnostics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type Segment
1.1.1.2. Product Segment
1.1.1.3. Technology segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Oncology Based Molecular Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Type and Product Snapshot
2.3. Technology Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Oncology Based Molecular Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Rising Global Cancer Prevalence
3.4.2. Adoption of Precision Medicine
3.4.3. Advances in Molecular Testing Technologies
3.5. Market Restraint Analysis
3.5.1. High Costs of Testing and Equipment
3.5.2. Inconsistent Reimbursement and Regulatory Frameworks
3.5.3. Limited Access in Low-Resource Regions
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Oncology Based Molecular Diagnostics Market: Type Estimates & Trend Analysis
4.1. Oncology Based Molecular Diagnostics Market: Type Movement Analysis
4.2. Breast Cancer
4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. Prostate Cancer
4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Colorectal Cancer
4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Cervical Cancer
4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Liver Cancer
4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Lung Cancer
4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Blood Cancer
4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Kidney Cancer
4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. Others
4.10.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Oncology Based Molecular Diagnostics Market: Product Estimates & Trend Analysis
5.1. Oncology Based Molecular Diagnostics Market: Product Movement Analysis
5.2. Instruments
5.2.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.3. Reagents
5.3.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.4. Others
5.4.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Oncology Based Molecular Diagnostics Market: Technology Estimates & Trend Analysis
6.1. Oncology Based Molecular Diagnostics Market: Product Movement Analysis
6.2. PCR
6.2.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.3. In situ hybridization
6.3.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.4. INAAT
6.4.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Chips and microarrays
6.5.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Mass spectrometry
6.6.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Sequencing
6.7.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.8. TMA
6.8.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.9. Others
6.9.1. Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Oncology Based Molecular Diagnostics Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Oncology Based Molecular Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.2.2.2. Key Country Dynamics
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Scenario
7.2.2.5. Competitive Scenario
7.2.3. Canada
7.2.3.1. Canada Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.2.3.2. Key Country Dynamics
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Scenario
7.2.3.5. Competitive Scenario
7.2.4. Mexico
7.2.4.1. Mexico Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.2.4.2. Key Country Dynamics
7.2.4.3. Regulatory Framework
7.2.4.4. Reimbursement Scenario
7.2.4.5. Competitive Scenario
7.3. Europe
7.3.1. Europe Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.2. UK
7.3.2.1. UK Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.2.2. Key Country Dynamics
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Scenario
7.3.2.5. Competitive Scenario
7.3.3. Germany
7.3.3.1. Germany Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.3.2. Key Country Dynamics
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Scenario
7.3.3.5. Competitive Scenario
7.3.4. Spain
7.3.4.1. Spain Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.4.2. Key Country Dynamics
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Scenario
7.3.4.5. Competitive Scenario
7.3.5. France
7.3.5.1. France Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.5.2. Key Country Dynamics
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Scenario
7.3.5.5. Competitive Scenario
7.3.6. Italy
7.3.6.1. Italy Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.6.2. Key Country Dynamics
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Scenario
7.3.6.5. Competitive Scenario
7.3.7. Denmark
7.3.7.1. Denmark Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.7.2. Key Country Dynamics
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Scenario
7.3.7.5. Competitive Scenario
7.3.8. Sweden
7.3.8.1. Sweden Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.8.2. Key Country Dynamics
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Scenario
7.3.8.5. Competitive Scenario
7.3.9. Norway
7.3.9.1. Norway Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.3.9.2. Key Country Dynamics
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Scenario
7.3.9.5. Competitive Scenario
7.4. Asia Pacific
7.4.1. Asia-Pacific Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.4.2.2. Key Country Dynamics
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Scenario
7.4.2.5. Competitive Scenario
7.4.3. China
7.4.3.1. China Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.4.3.2. Key Country Dynamics
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Scenario
7.4.3.5. Competitive Scenario
7.4.4. India
7.4.4.1. India Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.4.4.2. Key Country Dynamics
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Scenario
7.4.4.5. Competitive Scenario
7.4.5. South Korea
7.4.5.1. South Korea Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.4.5.2. Key Country Dynamics
7.4.5.3. Regulatory Framework
7.4.5.4. Reimbursement Scenario
7.4.5.5. Competitive Scenario
7.4.6. Thailand
7.4.6.1. Thailand Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.4.6.2. Key Country Dynamics
7.4.6.3. Regulatory Framework
7.4.6.4. Reimbursement Scenario
7.4.6.5. Competitive Scenario
7.4.7. Australia
7.4.7.1. Australia Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.4.7.2. Key Country Dynamics
7.4.7.3. Regulatory Framework
7.4.7.4. Reimbursement Scenario
7.4.7.5. Competitive Scenario
7.5. Latin America
7.5.1. Latin America Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.5.2.2. Key Country Dynamics
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Scenario
7.5.2.5. Competitive Scenario
7.5.3. Argentina
7.5.3.1. Argentina Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.5.3.2. Key Country Dynamics
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Scenario
7.5.3.5. Competitive Scenario
7.6. MEA
7.6.1. MEA Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.6.2.2. Key Country Dynamics
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Scenario
7.6.2.5. Competitive Scenario
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.6.3.2. Key Country Dynamics
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Scenario
7.6.3.5. Competitive Scenario
7.6.4. UAE
7.6.4.1. UAE Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.6.4.2. Key Country Dynamics
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Scenario
7.6.4.5. Competitive Scenario
7.6.5. Kuwait
7.6.5.1. Kuwait Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
7.6.5.2. Key Country Dynamics
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Scenario
7.6.5.5. Competitive Scenario
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. New Type Launch
8.2.2. Partnerships
8.2.3. Acquisition
8.2.4. Collaboration
8.2.5. Funding
8.3. Key Company Market Share Analysis, 2024
8.4. Company Heat Map Analysis
8.5. Company Profiles
8.5.1. Abbott
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Type Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Bayer AG
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Type Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. BD
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Type Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Cepheid
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Type Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Agilent Technologies, Inc.
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Type Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Danaher
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Type Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Hologic, Inc.
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Type Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Qiagen
8.5.8.1. Company Overview
8.5.8.2. Financial Performance
8.5.8.3. Type Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. F. Hoffmann-La Roche Ltd.
8.5.9.1. Company Overview
8.5.9.2. Financial Performance
8.5.9.3. Type Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Siemens
8.5.10.1. Company Overview
8.5.10.2. Financial Performance
8.5.10.3. Type Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Sysmex
8.5.11.1. Company Overview
8.5.11.2. Financial Performance
8.5.11.3. Type Benchmarking
8.5.11.4. Strategic Initiatives
List of Tables
Table. 1. List Of Secondary Sources
Table. 2. List Of Abbreviation
Table. 3. Global Oncology Based Molecular Diagnostics Market, By Region, 2021 - 2030 (USD Million)
Table. 4. Global Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 5. Global Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 6. Global Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 7. North America Oncology Based Molecular Diagnostics Market, By Country, 2021 - 2030 (USD Million)
Table. 8. North America Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 9. North America Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 10. North America Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 11. U.S. Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 12. U.S. Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 13. U.S. Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 14. Canada Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 15. Canada Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 16. Canada Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 17. Mexico Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 18. Mexico Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 19. Mexico Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 20. Europe Oncology Based Molecular Diagnostics Market, By Country, 2021 - 2030 (USD Million)
Table. 21. Europe Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 22. Europe Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 23. Europe Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 24. UK Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 25. UK Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 26. UK Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 27. Germany Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 28. Germany Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 29. Germany Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 30. France Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 31. France Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 32. France Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 33. Italy Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 34. Italy Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 35. Italy Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 36. Spain Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 37. Spain Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 38. Spain Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 39. Sweden Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 40. Sweden Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 41. Sweden Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 42. Norway Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 43. Norway Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 44. Norway Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 45. Denmark Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 46. Denmark Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 47. Denmark Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 48. Asia Pacific Oncology Based Molecular Diagnostics Market, By Country, 2021 - 2030 (USD Million)
Table. 49. Asia Pacific Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 50. Asia Pacific Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 51. Asia Pacific Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 52. Japan Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 53. Japan Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 54. Japan Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 55. China Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 56. China Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 57. China Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 58. India Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 59. India Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 60. India Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 61. Australia Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 62. Australia Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 63. Australia Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 64. Thailand Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 65. Thailand Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 66. Thailand Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 67. South Korea Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 68. South Korea Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 69. South Korea Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 70. Latin America Oncology Based Molecular Diagnostics Market, By Country, 2021 - 2030 (USD Million)
Table. 71. Latin America Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 72. Latin America Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 73. Latin America Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 74. Brazil Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 75. Brazil Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 76. Brazil Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 77. Argentina Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 78. Argentina Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 79. Argentina Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 80. MEA Oncology Based Molecular Diagnostics Market, By Country, 2021 - 2030 (USD Million)
Table. 81. MEA Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 82. MEA Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 83. MEA Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 84. South Africa Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 85. South Africa Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 86. South Africa Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 87. Saudi Arabia Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 88. Saudi Arabia Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 89. Saudi Arabia Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 90. UAE Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD Million)
Table. 91. UAE Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 92. UAE Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
Table. 93. Kuwait Oncology Based Molecular Diagnostics Market, By Technology, 2021 - 2030 (USD)
Table. 94. Kuwait Oncology Based Molecular Diagnostics Market, By Type, 2021 - 2030 (USD Million)
Table. 95. Kuwait Oncology Based Molecular Diagnostics Market, By Product, 2021 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Market Summary
Fig. 4 Market Segmentation & Scope
Fig. 5 Market Size and Growth Prospects
Fig. 6 Global Oncology Based Molecular Diagnostics Market- Key Market Driver Analysis
Fig. 7 Global Oncology Based Molecular Diagnostics Market - Key Market Restraint Analysis
Fig. 8 Penetration & Growth Prospect Mapping
Fig. 9 Global Oncology Based Molecular Diagnostics Market - Porter’s Analysis
Fig. 10 Global Oncology Based Molecular Diagnostics Market - PESTEL Analysis
Fig. 11 Global Oncology Based Molecular Diagnostics Market Type Outlook Key Takeaways
Fig. 12 Global Oncology Based Molecular Diagnostics Market: Type Movement Analysis
Fig. 13 Breast Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 14 Prostate Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 15 Colorectal Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 16 Cervical Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 17 Liver Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 18 Lung Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 19 Blood Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 20 Kidney Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 21 Others Cancer Market Estimates, 2021 - 2033 (USD Million)
Fig. 22 Global Oncology Based Molecular Diagnostics Market Product Outlook Key Takeaways
Fig. 23 Global Oncology Based Molecular Diagnostics Market: Product Movement Analysis
Fig. 24 Instruments Market Estimates, 2021 - 2033 (USD Million)
Fig. 25 Reagents Market Estimates, 2021 - 2033 (USD Million)
Fig. 26 Others Market Estimates, 2021 - 2033 (USD Million)
Fig. 27 Global Oncology Based Molecular Diagnostics Market Technology Outlook Key Takeaways
Fig. 28 Global Oncology Based Molecular Diagnostics Market: Technology Movement Analysis
Fig. 29 PCR Market Estimates, 2021 - 2033 (USD Million)
Fig. 30 In Situ Hybridization Market Estimates, 2021 - 2033 (USD Million)
Fig. 31 INAAT Market Estimates, 2021 - 2033 (USD Million)
Fig. 32 Chips and Microarrays Market Estimates, 2021 - 2033 (USD Million)
Fig. 33 Mass Spectrometry Market Estimates, 2021 - 2033 (USD Million)
Fig. 34 Sequencing Market Estimates, 2021 - 2033 (USD Million)
Fig. 35 TMA Market Estimates, 2021 - 2033 (USD Million)
Fig. 36 Others Market Estimates, 2021 - 2033 (USD Million)
Fig. 37 Regional Marketplace: Key Takeaways
Fig. 38 Global Oncology Based Molecular Diagnostics Market: Regional Movement Analysis
Fig. 39 North America Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 40 US Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 41 Canada Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 42 Mexico Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 43 Europe Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 44 UK Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 45 Germany Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 46 France Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 47 Spain Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 48 Italy Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 49 Denmark Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 50 Sweden Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 51 Norway Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 52 Asia Pacific Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 53 Japan Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 54 China Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 55 India Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 56 South Korea Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 57 Australia Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 58 Thailand Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 59 Latin America Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 60 Brazil Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 61 Argentina Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 62 MEA Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 63 South Africa Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 64 Saudi Arabia Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 65 UAE Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 66 Kuwait Oncology Based Molecular Diagnostics Market, 2021 - 2033 (USD Million)
Fig. 67 Strategy Framework

Companies Mentioned

  • Abbott
  • Bayer AG
  • BD
  • Cepheid
  • Agilent Technologies, Inc.
  • Danaher
  • Hologic, Inc.
  • Qiagen
  • F. Hoffmann-La Roche Ltd.
  • Siemens
  • Sysmex

Table Information

Report AttributeDetails
No. of Pages136
PublishedJuly 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 3.75 Billion
Forecasted Market Value ( USD ) by 2033 $ 6.35 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Nucleic Acids for Molecular Diagnosis Market by Product (Instruments, Reagents and Kits, Services), Technology (Microarrays, Next Generation Sequencing, Pcr), Application, Nucleic Acid Type, End User - Global Forecast 2025-2030 - Product Image

Nucleic Acids for Molecular Diagnosis Market by Product (Instruments, Reagents and Kits, Services), Technology (Microarrays, Next Generation Sequencing, Pcr), Application, Nucleic Acid Type, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Breath Molecular Diagnostic Device Market by Application (Cardiovascular Disorders, Infectious Disease, Metabolic Disorders), Technology (Digital PCR, Immunoassay, Mass Spectrometry), End User, Product Type, Sample Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Breath Molecular Diagnostic Device Market by Application (Cardiovascular Disorders, Infectious Disease, Metabolic Disorders), Technology (Digital PCR, Immunoassay, Mass Spectrometry), End User, Product Type, Sample Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
PCR Tests - Global Strategic Business Report - Product Image

PCR Tests - Global Strategic Business Report

  • Report
  • 479 Pages
  • Global
From
Biological PCR Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Biological PCR Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F - Product Image

Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F

  • Report
  • 188 Pages
  • Global
From

About the Oncology Based Molecular Diagnostics Market

The Oncology Based Molecular Diagnostics market intersects with the field of genomics to enhance the understanding and treatment of cancer. Molecular diagnostics involves analyzing biological markers in the genome and proteome by applying molecular biology to medical testing. In oncology, these diagnostic tools help to detect specific genetic mutations, epigenetic changes, and patterns of gene expression that are characteristic of different cancers. This information is then used for various purposes including cancer detection, prognostication, and the personalization of therapy. Advancements in genomic technologies have fostered the development of highly sensitive and specific tests capable of detecting minute amounts of cancer-related genetic material, even from circulating tumor cells or cell-free DNA. These innovations have made it possible for earlier detection, improved monitoring of treatment response, and the identification of potential therapeutic targets, thus contributing to precision medicine in oncology. Several companies operate within the Oncology Based Molecular Diagnostics market, harnessing genomic advancements to offer a range of services and products. Notable players include Illumina, Inc., known for their sequencing and array-based technologies for genomics analysis; Roche Molecular Diagnostics, part of the Roche Group, offering a variety of cancer-related diagnostic tools; Agilent Technologies, specializing in diagnostics including genomic analysis equipment and software; Thermo Fisher Scientific, which provides instruments, reagents, and software for molecular diagnostics; and Myriad Genetics, which offers predictive cancer testing and personalized medicine. These companies, among others, contribute to the development and application of molecular diagnostic technologies Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.